The BERNIE study: A phase II study evaluating addition of bevacizumab (Bv) to chemotherapy in children and adolescents with metastatic rhabdomyosarcoma (mRMS) and non-rhabdomyosarcoma soft tissue sarcoma (mNRSTS).
Julia C. Chisholm
Consultant or Advisory Role - Roche
Michela Casanova
Consultant or Advisory Role - Roche
Johannes H. Merks
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Birgit Geoerger
No relevant relationships to disclose
Raphael F. Rousseau
Employment or Leadership Position - Roche
Stock Ownership - Roche
Nicola Moore
Employment or Leadership Position - Roche
Stock Ownership - Roche
Christophe Dhalluin
Employment or Leadership Position - Roche
Odile Oberlin
Honoraria - Roche